The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes.
Open accessAbstract
Since high-affinity adenosine A2 receptors (A2a) are localized exclusively in dopamine-rich regions in the central nervous system and mediate inhibition of locomotor activity, we have examined the effect of A2a receptor activation on D1 and D2 receptor binding in membrane preparations of the rat striatum. The A2a agonist 2-[p-(2-carboxyethyl)phenethylamino]-5'- N-ethylcarboxamidoadenosine (CGS 21680) increased the Kd of the dopamine D2 agonist L-(-)-N-[3H]propylnorapomorphine without affecting the Bmax. The increase in Kd was maximal (40%) at 30 nM CGS 21680. CGS 21680 (30 nM) decreased the dopamine-induced inhibition of [3H]raclopride (a D2 antagonist) binding due to an increase (about 3-fold) in KH and KL, the dissociation constants of high- and low-affinity binding sites. The effects of CGS 21680 were antagonized by the adenosine antagonist 8-phenyltheophylline (10 microM). (-)-N6-(2-Phenylisopropyl)adenosine produced an effect similar to that of CGS 21680, provided the concentration used was high enough to stimulate A2a receptors (300 nM). GTP (50 microM) also decreased the dopamine-induced inhibition of [3H]raclopride binding but, in contrast to CGS 21680, GTP decreased the proportion of D2 receptors in the high-affinity state. CGS 21680 (30 nM) did not affect the Kd or Bmax of [3H]raclopride and failed to affect ligand binding to D1 receptors. Thus, stimulation of A2a receptors potently reduces the affinity of D2 agonist binding sites within the plasma membrane of striatal neurons. This A2a-D2 interaction may underlie the neuroleptic-like actions of adenosine agonists and the enhancing effects of adenosine antagonists, such as caffeine, on locomotor activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
LIGAND: A versatile computerized approach for characterization of ligand-binding systems
Munson, P. J., & Rodbard, D. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90515-1 · Cited by 8,429
Calker, D. V., Müller, M., & Hamprecht, B. (1979) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1979.tb05236.x · Cited by 1,371
Dopamine receptors and the dopamine hypothesis of schizophrenia
Seeman, P. (1987) · Synapse · doi:10.1002/syn.890010203 · Cited by 880
Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes.
Bruns, R. F., Lu, G. H., & Pugsley, T. A. (1986) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10259-9 · Cited by 830
Boyson, S., McGonigle, P., & Molinoff, P. (1986) · The Journal of Neuroscience · doi:10.1523/jneurosci.06-11-03177.1986 · Cited by 747
SCH 23390—The first selective dopamine D-1 antagonist
Hyttel, J. (1983) · European Journal of Pharmacology · doi:10.1016/0014-2999(83)90381-3 · Cited by 737
Adenosine receptors and behavioral actions of methylxanthines.
Snyder, S. H., Katims, J. J., Annau, Z., Bruns, R. F., & Daly, J. W. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.5.3260 · Cited by 694
The Physiological Role of Adenosine In The Central Nervous System
Dunwiddie, T. V. (1985) · International Review of Neurobiology · doi:10.1016/s0074-7742(08)60556-5 · Cited by 623
[3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.
Jarvis, M. F., Schulz, R., Hutchison, A. J., Do, U. H., Sills, M. A., & Williams, M. (1989) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21094-1 · Cited by 545
Modulation of neurotransmission by purine nucleotides and nucleosides
Fredholm, B. B., & Hedqvist, P. (1980) · Biochemical Pharmacology · doi:10.1016/0006-2952(80)90117-3 · Cited by 521
Self-citationKöhler, C., Hall, H., Ögren, S.-O., & Gawell, L. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90778-6 · Cited by 505
Snyder, S. H. (1985) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.08.030185.000535 · Cited by 467
Daly, J. W., Butts-Lamb, P., & Padgett, W. (1983) · Cellular and Molecular Neurobiology · doi:10.1007/bf00734999 · Cited by 442
The Classification of Dopamine Receptors: Relationship to Radioligand Binding
Creese, I., Sibley, D. R., Hamblin, M. W., & Leff, S. E. (1983) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.06.030183.000355 · Cited by 389
Jarvis, M. F., & Williams, M. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90571-2 · Cited by 339
RDC8 codes for an adenosine A2 receptor with physiological constitutive activity
Maenhaut, C., Van Sande, J., Libert, F., Abramowicz, M., Parmentier, M., Vanderhaegen, J.-J., Dumont, J. E., Vassart, G., & Schiffmann, S. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80909-x · Cited by 271
CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity.
Hutchison, A. J., Webb, R. L., Oei, H. H., Ghai, G. R., Zimmerman, M. B., & Williams, M. (1989) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20735-2 · Cited by 245
Onali, P., Olianas, M. C., & Gessa, G. L. (1985) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13494-9 · Cited by 237
Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain.
Seeman, P., Niznik, H. B., Guan, H. C., Booth, G., & Ulpian, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.10156 · Cited by 191
Effect of guanine nucleotides on striatal dopamine receptors
ZAHNISER, N. R., & MOLINOFF, P. B. (1978) · Nature · doi:10.1038/275453a0 · Cited by 184
Fuxé, K., & Ungerstedt, U. (1974) · PubMed · Cited by 170
Lupica, C. R., Cass, W. A., Zahniser, N. R., & Dunwiddie, T. V. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20171-9 · Cited by 169
Parkinson, F. E., & Fredholm, B. (1990) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00178977 · Cited by 149
Self-citationFerré, S., Herrera‐Marschitz, M., Grabowska‐Andén, M., Ungerstedt, U., Casas, M., & Andén, N. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90064-w · Cited by 124
The cellular localization of adenosine receptors in rat neostriatum
Alexander, S. P. H., & Reddington, M. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90011-0 · Cited by 121
Ferré, S., Herrera‐Marschitz, M., Grabowska‐Andén, M., Casas, M., Ungerstedt, U., & Andén, N. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90065-x · Cited by 105
Modulation of Striatal Dopaminergic Function by Local Injection of 5′- N -Ethylcarboxamide Adenosine
Green, R. D., Proudfit, H. K., & Yeung, S.-M. H. (1982) · Science · doi:10.1126/science.7123218 · Cited by 104
Effect of some phosphodiesterase inhibitors on central dopamine mechanisms
Fredholm, B. B., Fuxé, K., & Agnati, L. F. (1976) · European Journal of Pharmacology · doi:10.1016/0014-2999(76)90198-9 · Cited by 99
Self-citationSchiffmann, S. N., Libert, F., Vassart, G., Dumont, J. E., & Vanderhaeghen, J. J. (1990) · Brain Research · doi:10.1016/0006-8993(90)90097-u · Cited by 84
Durcan, M. J., & Morgan, P. F. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90789-9 · Cited by 80
Prémont, J., Pérez, M., BLANC, G., Tassin, J., Thierry, A. M., Hervé, D., & Bockaert, J. (1979) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13822-4 · Cited by 77
Sensitization by caffeine of central catecholamine receptors
Waldeck, B. (1973) · Journal of Neural Transmission · doi:10.1007/bf01244827 · Cited by 76
Onali, P., Olianas, M. C., & Bunse, B. (1988) · Brain Research · doi:10.1016/0006-8993(88)90232-6 · Cited by 71
l-glutamate reduces the affinity of [3H]N-propylnorapomorphine binding sites in striatal membranes
Fuxé, K., Celani, M. F., Martire, M., Zini, I., Zoli, M., & Agnati, L. F. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90326-1 · Cited by 29
Cited by
Receptors for Purines and Pyrimidines
Burnstock, G., & Verkhratsky, A. (2012) · Purinergic Signalling and the Nervous System · doi:10.1007/978-3-642-28863-0_5 · Cited by 3,958
Fredholm, B. B., Bättig, K., Holmén, J., Nehlig, A., & Zvartau, E. E. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01396-6 · Cited by 2,624
Self-citationInternational Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Klotz, K.-N., & Linden, J. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01511-4 · Cited by 2,585
Self-citationReceptors for Purines and Pyrimidines
Ralevic, V., & Burnstock, G. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01373-5 · Cited by 2,005
Adenosine Receptors as Therapeutic Targets
Jacobson, K. A., & Gao, Z.-G. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1983 · Cited by 1,431
Metadata
- Authors
- Ferre, S., von Euler, G., Johansson, B., Fredholm, B. B., & Fuxe, K.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1991-08-15
- Volume
- 88
- Issue
- 16
- Pages
- 7238-7241
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2062214351
- Cited by
- 552
- References
- 35
- FWCI
- 6.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.